TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GHRS

GH Research PLC

Healthcare · Biotechnology

22.90$ +0.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GHRS
Line item 2019 2020 2021 2022 2023 2024 2025
– +1,073.0% +4,634.8% -9.1% -11.0% -16.8% +53.1%
– +1,073.0% +4,633.5% -39.8% -2.6% -6.0% +85.4%
– +1,083.7% +4,595.1% -40.0% -52.7% +28.5% +144.3%
– +1,083.7% +4,595.1% -40.0% -2.6% -7.6% +88.0%
– – +700.0% +87.5% +97.8% +873.0% -25.2%
– – – -103.0% – – –
– – – +18.3% – – –
– +136.5% +1,017.5% +65.4% +61.3% +27.1% -8.5%
– +136.5% +1,017.5% +65.4% +47.4% +33.6% -6.4%
– – – – – -25.7% +43.1%
– -98.9% +88,200.0% +111.6% +86.8% +7.2% +0.9%
– +1,316.5% +4,791.9% -9.9% -12.3% -18.3% +56.3%
– – – – – – –
– +8.5% +71.3% +0.0% +0.0% +0.0% +17.3%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?